Astellas Pharma, Inc. (ALPMY)
14.18
+0.75
(+5.58%)
USD |
OTCM |
May 29, 16:00
Astellas Pharma Market Cap : 25.40B for May 29, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Daiichi Sankyo Co., Ltd. | 30.53B |
| Takeda Pharmaceutical Co., Ltd. | 50.41B |
| Eisai Co., Ltd. | 6.935B |
| Chugai Pharmaceutical Co., Ltd. | 81.23B |
| Santen Pharmaceutical Co., Ltd. | 3.870B |
Market Cap Related Metrics
| PE Ratio | 13.14 |
| PS Ratio | 1.795 |
| PEG Ratio | 0.027 |
| Price to Book Value | 2.207 |
| Price | 14.18 |
| Earnings Yield | 7.61% |
| PEGY Ratio | 0.027 |
| Operating PE Ratio | 9.120 |